Research Article | Volume: 7, Issue : 4, April, 2017

Application of simplex centroid design in formulation and optimization of floating matrix tablets of metformin

Meenakshi Bhavesh Patel Farhatjahan Shaikh Vandana Patel Naazneen Imtiaz Surti   

Open Access   

Published:  Apr 30, 2017

DOI: 10.7324/JAPS.2017.70403
Abstract

The purpose of this research work was to develop the buoyant matrices of metformin by the direct compression method using mixture design as an optimization technique. The simplex Centroid design was practiced as an optimization technique by modifying the quantity of three elements simultaneously and holding back their total concentration constant.

Method: The amounts of HPMC K15M (X1), kappa-Carrageenan (X2) and sodium bicarbonate (X3) were used as the independent variables while floating lag time (Y1), % drug released after 1 hour(Y2) and time required for 90% (t90) were taken as the response variables. As per the simplex centroid design total 14 formulations were formulated. Matrices were evaluated for physical parameters, in-vitro buoyancy, swelling ability and adhesion retention period.

Results: The results of response variables were statistically evaluated using design expert software. Formulation M-SCD 7 was found to be the optimum having good floating lag time and also matching the desirability criteria for drug release. The formulation also gave reasonably high adhesion retention period and swelling index desirable for securing the retention of formulation in the abdomen.

Conclusion: It was concluded that the mixture of kappa carrageenan and HPMC K 15 M increases the flexibility in the release pattern of the drug. This study establishes the use of simplex centroid design in the development of floating matrix tablets with minimum experimentation.


Keyword:     Simple centroid design mixture design metformin gastro retentive HPMC carrageenan.


Citation:

Patel MB, Shaikh F, Patel V, Surti NI. Application of simplex centroid design in formulation and optimization of floating matrix tablets of metformin. J App Pharm Sci, 2017; 7 (04): 023-030.

Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Article Metrics
435 Views 44 Downloads 479 Total

Year

Month

Related Search

By author names